Anna Maria Militello Teresa Zielli Daniela Boggiani Maria Michiara Nadia Naldi Beatrice Bortesi Paola Zanelli Vera Uliana Sara Giuliotti Antonino Musolino
10.3389/fonc.2019.00759
Front Oncol
2019 Aug 13;9:759.
brca cdk4/6 inhibitor breast cancer cyclin d1 endocrine therapy estrogen receptor homologous recombination
CC BY
https://pubmed.ncbi.nlm.nih.gov/31456944/
Case Reports
PMC6700293
31456944
Mechanism of Action and Clinical Efficacy of CDK4/6 Inhibitors in BRCA-Mutated, Estrogen Receptor-Positive Breast Cancers: Case Report and Literature Review
2019